US Bancorp’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70.9K | Buy |
1,207
+108
| +10% | +$4.53K | ﹤0.01% | 2625 |
|
|
2026
Q1 | $35.4K | Sell |
1,099
-304
| -22% | -$11.3K | ﹤0.01% | 2849 |
|
|
2025
Q4 | $59.1K | Buy |
1,403
+31
| +2% | +$1.25K | ﹤0.01% | 2623 |
|
|
2025
Q3 | $47.1K | Sell |
1,372
-167
| -11% | -$4.79K | ﹤0.01% | 2700 |
|
|
2025
Q2 | $41.6K | Buy |
1,539
+116
| +8% | +$3.36K | ﹤0.01% | 2860 |
|
|
2025
Q1 | $42.2K | Sell |
1,423
-351
| -20% | -$13.4K | ﹤0.01% | 2830 |
|
|
2024
Q4 | $70.3K | Buy |
1,774
+647
| +57% | +$24.5K | ﹤0.01% | 2571 |
|
|
2024
Q3 | $38.4K | Sell |
1,127
-2,415
| -68% | -$67.9K | ﹤0.01% | 2866 |
|
|
2024
Q2 | $76.8K | Buy |
3,542
+187
| +6% | +$3.93K | ﹤0.01% | 2462 |
|
|
2024
Q1 | $74.3K | Buy |
3,355
+402
| +14% | +$9.81K | ﹤0.01% | 2498 |
|
|
2023
Q4 | $81.2K | Buy |
2,953
+18
| +0.6% | +$435 | ﹤0.01% | 2431 |
|
|
2023
Q3 | $65.5K | Buy |
2,935
+115
| +4% | +$2.96K | ﹤0.01% | 2323 |
|
|
2023
Q2 | $71.8K | Buy |
2,820
+56
| +2% | +$1.36K | ﹤0.01% | 2343 |
|
|
2023
Q1 | $61.6K | Buy |
2,764
+30
| +1% | +$725 | ﹤0.01% | 2411 |
|
|
2022
Q4 | $64.9K | Sell |
2,734
-2,623
| -49% | -$61K | ﹤0.01% | 2396 |
|
|
2022
Q3 | $88K | Sell |
5,357
-659
| -11% | -$14.8K | ﹤0.01% | 2258 |
|
|
2022
Q2 | $119K | Sell |
6,016
-540
| -8% | -$10.9K | ﹤0.01% | 2144 |
|
|
2022
Q1 | $180K | Buy |
6,556
+336
| +5% | +$9.61K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $256K | Sell |
6,220
-185
| -3% | -$8.17K | ﹤0.01% | 1857 |
|
|
2021
Q3 | $297K | Sell |
6,405
-3,900
| -38% | -$170K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $413K | Buy |
10,305
+3,097
| +43% | +$132K | ﹤0.01% | 1648 |
|
|
2021
Q1 | $387K | Buy |
7,208
+3,719
| +107% | +$214K | ﹤0.01% | 1623 |
|
|
2020
Q4 | $171K | Sell |
3,489
-155
| -4% | -$7.18K | ﹤0.01% | 1938 |
|
|
2020
Q3 | $118K | Buy |
3,644
+155
| +4% | +$4.93K | ﹤0.01% | 2014 |
|
|
2020
Q2 | $90K | Sell |
3,489
-715
| -17% | -$17.8K | ﹤0.01% | 2166 |
|
|
2020
Q1 | $103K | Buy |
4,204
+101
| +2% | +$2.54K | ﹤0.01% | 2010 |
|
|
2019
Q4 | $114K | Sell |
4,103
-40
| -1% | -$1.03K | ﹤0.01% | 2112 |
|
|
2019
Q3 | $100K | Buy |
4,143
+1,227
| +42% | +$32.6K | ﹤0.01% | 2158 |
|
|
2019
Q2 | $83K | Buy |
2,916
+2,461
| +541% | +$61.5K | ﹤0.01% | 2305 |
|
|
2019
Q1 | $11K | Hold |
455
| – | – | ﹤0.01% | 3039 |
|
|
2018
Q4 | $6K | Hold |
455
| – | – | ﹤0.01% | 3176 |
|
|
2018
Q3 | $4K | Buy |
+455
| New | +$5.02K | ﹤0.01% | 3381 |
|
|
2014
Q3 | – | Sell |
-47
| Closed | -$1K | – | 3577 |
|
|
2014
Q2 | $1K | Hold |
47
| – | – | ﹤0.01% | 3438 |
|
|
2014
Q1 | $1K | Hold |
47
| – | – | ﹤0.01% | 3422 |
|
|
2013
Q4 | $1K | Buy |
+47
| New | +$612 | ﹤0.01% | 3362 |
|
Other funds holding VCYT
AIM
US Bancorp's VCYT Position: Q2 2026 in Review
US Bancorp increased its Veracyte (VCYT) stake by 9.8% in Q2 2026, buying an estimated $4.53K and bringing the position to 1,207 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.
US Bancorp first reported a position in VCYT in Q4 2013 and has held it in 35 quarters since. The position peaked at $413K in Q2 2021. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- US Bancorp held 1,207 shares of Veracyte worth $70.9K as of Q2 2026.
- US Bancorp bought 108 Veracyte shares in Q2 2026, an estimated $4.53K.
- Veracyte made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2625 holding.
- US Bancorp first reported a position in Veracyte in Q4 2013 and has held it in 35 quarters since.
- US Bancorp's Veracyte position peaked at $413K in Q2 2021.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.